JPMorgan Chase & Co. Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $1,413.00 to $1,200.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 10.64% from the company’s previous close.

A number of other research analysts also recently issued reports on MTD. Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Morgan Stanley dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 10th. Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research report on Monday. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and boosted their target price for the stock from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Citigroup dropped their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $1,437.00.

Mettler-Toledo International Stock Down 3.5%

Shares of Mettler-Toledo International stock traded down $39.84 on Monday, reaching $1,084.62. The stock had a trading volume of 163,567 shares, compared to its average volume of 154,988. The company has a 50 day moving average price of $1,276.49 and a 200 day moving average price of $1,367.66. Mettler-Toledo International has a 1 year low of $1,087.12 and a 1 year high of $1,525.17. The stock has a market capitalization of $21.96 billion, a P/E ratio of 25.46, a P/E/G ratio of 2.36 and a beta of 1.31.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. During the same quarter in the previous year, the firm earned $8.19 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, analysts forecast that Mettler-Toledo International will post 46.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. The trade was a 13.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.71% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Institutional investors and hedge funds have recently bought and sold shares of the business. Principal Financial Group Inc. lifted its stake in shares of Mettler-Toledo International by 2.9% in the 3rd quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock valued at $366,354,000 after purchasing an additional 8,360 shares during the period. Nordea Investment Management AB lifted its stake in shares of Mettler-Toledo International by 11.9% in the 4th quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock valued at $220,718,000 after purchasing an additional 16,777 shares during the period. Campbell & CO Investment Adviser LLC acquired a new position in Mettler-Toledo International during the third quarter worth $2,210,000. Rakuten Investment Management Inc. acquired a new position in Mettler-Toledo International during the third quarter worth $121,021,000. Finally, Machina Capital S.A.S. acquired a new position in Mettler-Toledo International during the third quarter worth $1,186,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.